BREAKING NEWS: FDA grants full approval to Pfizer for its COVID-19 vaccine

The U.S. Food and Drug Administration (FDA) granted full approval to Pfizer-BioNTech’s coronavirus vaccine for those aged 16 and older on Monday.

The two-dose immunization was the first to receive emergency use authorization from federal regulators in December 2020 and will now be first to be licensed.

Full approval by the FDA could push more Americans to get the COVID-19 vaccine because it might reduce their fears about the safety of the shot.

It may also lead to more vaccine mandates with businesses feeling more comfortable requiring workers to get a jab that has full authorization.

CONTINUE READING ON DAILY MAIL

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

BPR INSIDER COMMENTS

Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!

Latest Articles